Journal: International Journal of Molecular Sciences

Article Title: Cyclophilin A Inhibitors Suppress Proliferation and Induce Apoptosis of MKN45 Gastric Cancer Stem-like Cells by Regulating CypA/CD147-Mediated Signaling Pathway

doi: 10.3390/ijms24054734

Figure Lengend Snippet: Expression levels of key gastric cancer stem cell (GCSC) markers, CypA, and CD147 in MKN45 adherent and tumorsphere cells. Protein levels were detected via Western blot analysis using specific antibodies and were further quantified using densitometry. β-actin levels were used as an internal control. The ratio of each target protein to β-actin for adherent cells was normalized to onefold. * p < 0.05 vs. the adherent cells.

Article Snippet: Antibodies against CypA (#2175), CD147 (#13287), CD44 (#37259), CD133 (#64326), integrin α6 (#3750), Sox2 (#3579), Nanog (#3580), Oct4 (#2750), ALDH1A1 (#12035), p53 (#2524), p21 Waf1/Cip1 (#2947), cleaved caspase-9 (#9501), cleaved caspase-3 (#9661), cleaved PARP (#9542), phospho-AKT (#4060), AKT (#9272), phospho-ERK1/2 (#9101), ERK1/2 (#9102), phospho-p38 (#4511), p38 (#8690), rabbit IgG (#7074), and mouse IgG (#7076) were purchased from Cell Signaling Technology (Danvers, MA, USA).

Techniques: Expressing, Western Blot

Journal: International Journal of Molecular Sciences

Article Title: Cyclophilin A Inhibitors Suppress Proliferation and Induce Apoptosis of MKN45 Gastric Cancer Stem-like Cells by Regulating CypA/CD147-Mediated Signaling Pathway

doi: 10.3390/ijms24054734

Figure Lengend Snippet: Effects of C9 and CsA on the CypA/CD147-mediated signaling pathways in MKN45 GCSCs. ( A , B ) MKN45-derived GCSCs were treated with the indicated concentrations of each compound for 72 h. Protein levels were detected via Western blot analysis using specific antibodies and were further quantified using densitometry. β-actin levels were used as an internal control. The ratio of each target protein to β-actin for untreated control was normalized to onefold. * p < 0.05 vs. the control.

Article Snippet: Antibodies against CypA (#2175), CD147 (#13287), CD44 (#37259), CD133 (#64326), integrin α6 (#3750), Sox2 (#3579), Nanog (#3580), Oct4 (#2750), ALDH1A1 (#12035), p53 (#2524), p21 Waf1/Cip1 (#2947), cleaved caspase-9 (#9501), cleaved caspase-3 (#9661), cleaved PARP (#9542), phospho-AKT (#4060), AKT (#9272), phospho-ERK1/2 (#9101), ERK1/2 (#9102), phospho-p38 (#4511), p38 (#8690), rabbit IgG (#7074), and mouse IgG (#7076) were purchased from Cell Signaling Technology (Danvers, MA, USA).

Techniques: Derivative Assay, Western Blot

Journal: BioMed Research International

Article Title: Downregulation of CyclophilinA/CD147 Axis Induces Cell Apoptosis and Inhibits Glioma Aggressiveness

doi: 10.1155/2020/7035847

Figure Lengend Snippet: Expressions of CyPA and CD147 are associated with glioma grade, histological type, and prognosis. The expression of CyPA (a) and CD147 (b) in GBM and LGG compared with normal tissue and correlation with prognosis in TCGA and CGGA databases. The expression of CyPA (c) and CD147 (d) in different WHO grades and histological types of glioma in TCGA and CGGA database. ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗∗ P < 0.0001, ns stands for no significance.

Article Snippet: After the blockade of nonspecific binding, tissue sections were incubated with the Cyclophilin A antibody (cat. no. 5360s; 1 : 150 dilution; Santa Cruz Biotechnology, Inc.) and CD147 antibody (cat. no. 13287; 1 : 400 dilution; Cell Signaling Technology, Inc.) for overnight at 4 centigrade.

Techniques: Expressing

Journal: BioMed Research International

Article Title: Downregulation of CyclophilinA/CD147 Axis Induces Cell Apoptosis and Inhibits Glioma Aggressiveness

doi: 10.1155/2020/7035847

Figure Lengend Snippet: Expression and knockdown of CyPA and CD147 in glioma cell lines. The expressions of CyPA (a) and CD147 (b) in glioma cell lines are detected by RT-qPCR and western blot.(c) Specific si-RNA could inhibit CyPA and CD147 expression in U251 cell line. ∗ P < 0.05, ∗∗∗ P < 0.001, ∗∗∗∗ P < 0.0001.

Article Snippet: After the blockade of nonspecific binding, tissue sections were incubated with the Cyclophilin A antibody (cat. no. 5360s; 1 : 150 dilution; Santa Cruz Biotechnology, Inc.) and CD147 antibody (cat. no. 13287; 1 : 400 dilution; Cell Signaling Technology, Inc.) for overnight at 4 centigrade.

Techniques: Expressing, Quantitative RT-PCR, Western Blot

Journal: BioMed Research International

Article Title: Downregulation of CyclophilinA/CD147 Axis Induces Cell Apoptosis and Inhibits Glioma Aggressiveness

doi: 10.1155/2020/7035847

Figure Lengend Snippet: Knockdown of CyPA and CD147 reduces glioma proliferation. (a). EdU assay shows that inhibition of CyPA and CD147 significantly decreases glioma cell proliferation. U251 wild type cell is taken as the control group. (b). Flow cytometry analysis reveals the effect of CyPA and CD147 inhibition on glioma cell proliferation.

Article Snippet: After the blockade of nonspecific binding, tissue sections were incubated with the Cyclophilin A antibody (cat. no. 5360s; 1 : 150 dilution; Santa Cruz Biotechnology, Inc.) and CD147 antibody (cat. no. 13287; 1 : 400 dilution; Cell Signaling Technology, Inc.) for overnight at 4 centigrade.

Techniques: EdU Assay, Inhibition, Flow Cytometry

Journal: BioMed Research International

Article Title: Downregulation of CyclophilinA/CD147 Axis Induces Cell Apoptosis and Inhibits Glioma Aggressiveness

doi: 10.1155/2020/7035847

Figure Lengend Snippet: Predictive value of CyPA and CD147 in different grades of glioma. CyPA and CD147 expression pattern in different grades of glioma in TCGA database (a) and CGGA database (b) analyzed by ROC curve analysis.

Article Snippet: After the blockade of nonspecific binding, tissue sections were incubated with the Cyclophilin A antibody (cat. no. 5360s; 1 : 150 dilution; Santa Cruz Biotechnology, Inc.) and CD147 antibody (cat. no. 13287; 1 : 400 dilution; Cell Signaling Technology, Inc.) for overnight at 4 centigrade.

Techniques: Expressing

Journal: BMC Cancer

Article Title: EMMPRIN expression is associated with metastatic progression in osteosarcoma

doi: 10.1186/s12885-021-08774-9

Figure Lengend Snippet: Decrease in invasion activities of SaOS-2 cells transfected by EMMPRIN siRNA. Matrigel invasion assays after transfection of the EMMRIN siRNA into SaOS-2 cells for 24 h. Following incubation, the membranes were removed from the inserts and mounted on slides. a. The number of invading cells was counted under a light microscope. The Matrigel assay was performed in triplicates. * p < 0.05 compared with cells transfected with control siRNA. b. Representative images of Matrigel invasion assay. Scale bar, 100 μm

Article Snippet: The membranes were probed with primary antibodies against EMMPRIN (Cell Signaling, #13287S, Lot1) after incubating in a blocking buffer.

Techniques: Transfection, Incubation, Light Microscopy, Matrigel Assay, Invasion Assay

Journal: BMC Cancer

Article Title: EMMPRIN expression is associated with metastatic progression in osteosarcoma

doi: 10.1186/s12885-021-08774-9

Figure Lengend Snippet: EMMPRIN silencing inhibits the metastatic nodes in the lungs. a Metastasis assay by tail vein injection of shRNA transfected 143B cells in BALB/c mice. Lungs were excised for examination at 8 weeks post-injection. The number of lung metastatic nodes was assessed by Bouin’s stain. Arrows indicate visible lung surface metastases. b Tumor volume and c Number of nodules at the study end point. d 143B cells were transfected with mock shRNA and EMMPRIN shRNA for 48 h, and cell lysates were analyzed by western blot using anti-EMMPRIN antibody. β-actin was used as a loading control. e Microscope images by H&E staining show that EMMPRIN silencing significantly inhibits the lung metastatic nodes after inoculation with 143B, 2 × 10 5 cells/ 200 ul. *, p < 0.05 compared with cells transfected with control siRNA. Scale bar, 100 μm. Original magnification, × 10 and × 40

Article Snippet: The membranes were probed with primary antibodies against EMMPRIN (Cell Signaling, #13287S, Lot1) after incubating in a blocking buffer.

Techniques: Injection, shRNA, Transfection, Staining, Western Blot, Microscopy

Journal: Experimental and Therapeutic Medicine

Article Title: CD147 promotes epithelial-mesenchymal transition of prostate cancer cells via the Wnt/β-catenin pathway

doi: 10.3892/etm.2020.9058

Figure Lengend Snippet: mRNA and protein expression levels of CD147 in LNCaP cells depleted of CD147 as detected by reverse transcription-quantitative polymerase chain reaction and western blotting. (A) mRNA and (B) protein expression in LNCaP/Scramble and LNCaP/shCD147 cells. Values are presented as the mean ± standard deviation of three experiments. ** P<0.01 vs. LNCaP/Scramble. LNCaP, lymph node carcinoma of the prostate; sh, short hairpin RNA.

Article Snippet: The membranes were then blocked with 5% nonfat milk in PBS containing 0.05% Tween-20 at room temperature for 2 h. The membranes were incubated with rabbit monoclonal antibodies against CD147 (cat. no. 13287), human p-glycogen synthase kinase (GSK)-3β (Ser 9; cat. no. 9322), GSK-3β (cat. no. 9315), E-cadherin (cat. no. 3195), N-cadherin (cat. no. 13116), vimentin (cat. no. 5741), β-catenin (cat. no. 8480), p-β-catenin (Ser 33/37/Thr 41; cat. no. 9561) and Snail (cat. no. 3879) all at 1:1,000 dilution (Cell Signaling Technology, Inc.) overnight at 4˚C. β-actin (cat. no. 4970) and lamin B (cat. no. 13435) were used as loading controls (both 1:2,000; Cell Signaling Technology, Inc.).

Techniques: Expressing, Real-time Polymerase Chain Reaction, Western Blot, Standard Deviation, shRNA

Journal: Experimental and Therapeutic Medicine

Article Title: CD147 promotes epithelial-mesenchymal transition of prostate cancer cells via the Wnt/β-catenin pathway

doi: 10.3892/etm.2020.9058

Figure Lengend Snippet: CD147 promotes LNCaP cell viability. LNCaP/shCD147 and LNCaP/Scramble cells were seeded in 96-well plates and incubated for 2, 4, 6 or 8 days. Cell viability was determined using a Cell Counting Kit-8 assay. Values are normalized to LNCaP/Scramble and presented as the mean ± standard deviation of three experiments. LNCaP, lymph node carcinoma of the prostate; sh, short hairpin RNA.

Article Snippet: The membranes were then blocked with 5% nonfat milk in PBS containing 0.05% Tween-20 at room temperature for 2 h. The membranes were incubated with rabbit monoclonal antibodies against CD147 (cat. no. 13287), human p-glycogen synthase kinase (GSK)-3β (Ser 9; cat. no. 9322), GSK-3β (cat. no. 9315), E-cadherin (cat. no. 3195), N-cadherin (cat. no. 13116), vimentin (cat. no. 5741), β-catenin (cat. no. 8480), p-β-catenin (Ser 33/37/Thr 41; cat. no. 9561) and Snail (cat. no. 3879) all at 1:1,000 dilution (Cell Signaling Technology, Inc.) overnight at 4˚C. β-actin (cat. no. 4970) and lamin B (cat. no. 13435) were used as loading controls (both 1:2,000; Cell Signaling Technology, Inc.).

Techniques: Incubation, Cell Counting, Standard Deviation, shRNA

Journal: Experimental and Therapeutic Medicine

Article Title: CD147 promotes epithelial-mesenchymal transition of prostate cancer cells via the Wnt/β-catenin pathway

doi: 10.3892/etm.2020.9058

Figure Lengend Snippet: CD147 promotes the migration and invasion of LNCaP cells. Effect of CD147 knockdown on (A) migration and (B) invasion of LNCaP cells. Scale bars, 20 µm. Values shown are presented as the mean ± standard deviation of three experiments. ** P<0.01 vs. LNCaP/Scramble. LNCaP, lymph node carcinoma of the prostate; sh, short hairpin RNA.

Article Snippet: The membranes were then blocked with 5% nonfat milk in PBS containing 0.05% Tween-20 at room temperature for 2 h. The membranes were incubated with rabbit monoclonal antibodies against CD147 (cat. no. 13287), human p-glycogen synthase kinase (GSK)-3β (Ser 9; cat. no. 9322), GSK-3β (cat. no. 9315), E-cadherin (cat. no. 3195), N-cadherin (cat. no. 13116), vimentin (cat. no. 5741), β-catenin (cat. no. 8480), p-β-catenin (Ser 33/37/Thr 41; cat. no. 9561) and Snail (cat. no. 3879) all at 1:1,000 dilution (Cell Signaling Technology, Inc.) overnight at 4˚C. β-actin (cat. no. 4970) and lamin B (cat. no. 13435) were used as loading controls (both 1:2,000; Cell Signaling Technology, Inc.).

Techniques: Migration, Standard Deviation, shRNA

Journal: Experimental and Therapeutic Medicine

Article Title: CD147 promotes epithelial-mesenchymal transition of prostate cancer cells via the Wnt/β-catenin pathway

doi: 10.3892/etm.2020.9058

Figure Lengend Snippet: CD147 promotes epithelial-mesenchymal transition of LNCaP cells. The expression of the epithelial marker E-cadherin and the mesenchymal markers N-cadherin and vimentin was determined in LNCaP/Scramble and LNCaP/shCD147 cells by western blotting. Values shown are presented as the mean ± standard deviation of three experiments. ** P<0.01 vs. LNCaP/Scramble. LNCaP, lymph node carcinoma of the prostate; sh, short hairpin RNA.

Article Snippet: The membranes were then blocked with 5% nonfat milk in PBS containing 0.05% Tween-20 at room temperature for 2 h. The membranes were incubated with rabbit monoclonal antibodies against CD147 (cat. no. 13287), human p-glycogen synthase kinase (GSK)-3β (Ser 9; cat. no. 9322), GSK-3β (cat. no. 9315), E-cadherin (cat. no. 3195), N-cadherin (cat. no. 13116), vimentin (cat. no. 5741), β-catenin (cat. no. 8480), p-β-catenin (Ser 33/37/Thr 41; cat. no. 9561) and Snail (cat. no. 3879) all at 1:1,000 dilution (Cell Signaling Technology, Inc.) overnight at 4˚C. β-actin (cat. no. 4970) and lamin B (cat. no. 13435) were used as loading controls (both 1:2,000; Cell Signaling Technology, Inc.).

Techniques: Expressing, Marker, Western Blot, Standard Deviation, shRNA

Journal: Experimental and Therapeutic Medicine

Article Title: CD147 promotes epithelial-mesenchymal transition of prostate cancer cells via the Wnt/β-catenin pathway

doi: 10.3892/etm.2020.9058

Figure Lengend Snippet: CD147 regulates epithelial-mesenchymal transition via the Wnt/β-catenin pathway. (A and B) Expression of β-catenin, Snail and p-GSK-3β (Ser9) was determined in LNCaP/Scramble and LNCaP/shCD147 cells by western blotting. (C and D) Expression of β-catenin, Snail, p-β-catenin (Ser33/37/Thr41), vimentin and E-cadherin following treatment with or without LiCl in LNCaP/Scramble and LNCaP/shCD147 cells by western blotting. Values are presented as the mean ± standard deviation of three experiments. Lanes 1 and 3, LNCaP/Scramble group; Lanes 2 and 4, LNCaP/shCD147 group. * P<0.05, ** P<0.01 vs. LNCaP/Scramble; # P<0.05, ## P<0.01 vs. LNCaP/shCD147. LNCaP, lymph node carcinoma of the prostate; LiCl, lithium chloride; sh, short hairpin RNA; p-, phosphorylated; GSK-3β, glycogen synthase kinase-3β.

Article Snippet: The membranes were then blocked with 5% nonfat milk in PBS containing 0.05% Tween-20 at room temperature for 2 h. The membranes were incubated with rabbit monoclonal antibodies against CD147 (cat. no. 13287), human p-glycogen synthase kinase (GSK)-3β (Ser 9; cat. no. 9322), GSK-3β (cat. no. 9315), E-cadherin (cat. no. 3195), N-cadherin (cat. no. 13116), vimentin (cat. no. 5741), β-catenin (cat. no. 8480), p-β-catenin (Ser 33/37/Thr 41; cat. no. 9561) and Snail (cat. no. 3879) all at 1:1,000 dilution (Cell Signaling Technology, Inc.) overnight at 4˚C. β-actin (cat. no. 4970) and lamin B (cat. no. 13435) were used as loading controls (both 1:2,000; Cell Signaling Technology, Inc.).

Techniques: Expressing, Western Blot, Standard Deviation, shRNA

Journal: Translational Cancer Research

Article Title: CD147 promotes glucose metabolism, invasion and metastasis via PI3K/AKT pathway in oral squamous cell carcinomas

doi: 10.21037/tcr.2019.07.50

Figure Lengend Snippet: CD147-shRNA3 resulted in maximum inhibition of CD147 mRNA (A) and protein (B) expression levels. *, P<0.05 compared to the control group; @ , P<0.05 compared to CD147-shRNA1; $ , P<0.05 compared to CD147-shRNA2.

Article Snippet: The proteins were electro-transferred to PVDF membranes, and blocked with 5% albumin bovine V (10735086001, Roche, USA) in Tris-buffered saline containing 0.5% Tween 20 (TBST buffer) at room temperature for 2 h. The membranes were then incubated overnight with the specific primary antibodies against CD147 (#13287), PI3K (#4249), p-PI3K (#4228), PDK1 (#5662), p-PDK1 (#3438), AKT (#9272), p-AKT (#4058), GLUT-1 (#12939) and GAPDH (#8884; all from Cell Signal Technology, USA).

Techniques: Inhibition, Expressing

Journal: Translational Cancer Research

Article Title: CD147 promotes glucose metabolism, invasion and metastasis via PI3K/AKT pathway in oral squamous cell carcinomas

doi: 10.21037/tcr.2019.07.50

Figure Lengend Snippet: CD147 silencing increased glucose uptake (left panel) and lactate secretion (right panel) in SCC-25 (A) and CAL-27 (B) cells in an shRNA dose-dependent manner. *, P<0.05 compared to the control group; @ , P<0.05 compared to 50 ng/mL CD147 shRNA; $ , P<0.05 compared to 100 ng/mL CD147 shRNA; & , P<0.05 compared to 150 ng/mL CD147 shRNA.

Article Snippet: The proteins were electro-transferred to PVDF membranes, and blocked with 5% albumin bovine V (10735086001, Roche, USA) in Tris-buffered saline containing 0.5% Tween 20 (TBST buffer) at room temperature for 2 h. The membranes were then incubated overnight with the specific primary antibodies against CD147 (#13287), PI3K (#4249), p-PI3K (#4228), PDK1 (#5662), p-PDK1 (#3438), AKT (#9272), p-AKT (#4058), GLUT-1 (#12939) and GAPDH (#8884; all from Cell Signal Technology, USA).

Techniques: shRNA

Journal: Translational Cancer Research

Article Title: CD147 promotes glucose metabolism, invasion and metastasis via PI3K/AKT pathway in oral squamous cell carcinomas

doi: 10.21037/tcr.2019.07.50

Figure Lengend Snippet: CD147 regulated the expression of key proteins of the PI3K/AKT pathway in SCC-25 and CAL-27 cells. Western blot analyses of PI3K, p-PI3K, PDK1, p-PDK1, AKT and p-AKT levels in SCC-25 (A) and CAL-27 cells (B). *, P<0.05 compared to control; @ , P<0.05 compared to 50 ng/mL CD147 shRNA; $ , P<0.05 compared to 100 ng/mL CD147 shRNA; & , P<0.05 compared to 150 ng/mL CD147 shRNA.

Article Snippet: The proteins were electro-transferred to PVDF membranes, and blocked with 5% albumin bovine V (10735086001, Roche, USA) in Tris-buffered saline containing 0.5% Tween 20 (TBST buffer) at room temperature for 2 h. The membranes were then incubated overnight with the specific primary antibodies against CD147 (#13287), PI3K (#4249), p-PI3K (#4228), PDK1 (#5662), p-PDK1 (#3438), AKT (#9272), p-AKT (#4058), GLUT-1 (#12939) and GAPDH (#8884; all from Cell Signal Technology, USA).

Techniques: Expressing, Western Blot, shRNA

Journal: Translational Cancer Research

Article Title: CD147 promotes glucose metabolism, invasion and metastasis via PI3K/AKT pathway in oral squamous cell carcinomas

doi: 10.21037/tcr.2019.07.50

Figure Lengend Snippet: CD147 regulated glucose metabolism via the PI3K/AKT pathway in SCC-25 and CAL-27 cells. SCC-25 and CAL-27 cells were transfected with PI3K-overexpressing plasmid and CD147 shRNAs. The glucose content and lactate production (A,C), and GLUT-1 expression (B,D) in the co-transfected SCC-25 (A,B) and CAL-27 (C,D) cells. *, P<0.05 compared to control; @ , P<0.05 compared to PI3K OE group; $ , P<0.05 compared to CD147 shRNA vector group.

Article Snippet: The proteins were electro-transferred to PVDF membranes, and blocked with 5% albumin bovine V (10735086001, Roche, USA) in Tris-buffered saline containing 0.5% Tween 20 (TBST buffer) at room temperature for 2 h. The membranes were then incubated overnight with the specific primary antibodies against CD147 (#13287), PI3K (#4249), p-PI3K (#4228), PDK1 (#5662), p-PDK1 (#3438), AKT (#9272), p-AKT (#4058), GLUT-1 (#12939) and GAPDH (#8884; all from Cell Signal Technology, USA).

Techniques: Transfection, Plasmid Preparation, Expressing, shRNA

Journal: Translational Cancer Research

Article Title: CD147 promotes glucose metabolism, invasion and metastasis via PI3K/AKT pathway in oral squamous cell carcinomas

doi: 10.21037/tcr.2019.07.50

Figure Lengend Snippet: The effect of CD147 silencing on the invasion and metastasis of SCC-25 cells. *, P<0.05 compared to control; @ , P<0.05 compared to 50 ng/mL CD147 shRNA; $ , P<0.05 compared to 100 ng/mL CD147 shRNA; & , P<0.05 compared to 150 ng/mL CD147 shRNA. Magnification: ×200, scale bar =50 µm; Crystal Violet Staining (0.1%).

Article Snippet: The proteins were electro-transferred to PVDF membranes, and blocked with 5% albumin bovine V (10735086001, Roche, USA) in Tris-buffered saline containing 0.5% Tween 20 (TBST buffer) at room temperature for 2 h. The membranes were then incubated overnight with the specific primary antibodies against CD147 (#13287), PI3K (#4249), p-PI3K (#4228), PDK1 (#5662), p-PDK1 (#3438), AKT (#9272), p-AKT (#4058), GLUT-1 (#12939) and GAPDH (#8884; all from Cell Signal Technology, USA).

Techniques: shRNA, Staining

Journal: Translational Cancer Research

Article Title: CD147 promotes glucose metabolism, invasion and metastasis via PI3K/AKT pathway in oral squamous cell carcinomas

doi: 10.21037/tcr.2019.07.50

Figure Lengend Snippet: CD147 facilitated invasion and metastasis of SCC-25 (A) and CAL-27 (B) cells via the PI3K/AKT pathway. *, P<0.05 compared to control; @ , P<0.05 compared to PI3K OE group; $ , P<0.05 compared to the CD147 shRNA vector group. Magnification: ×100, scale bar =100 µm; Crystal Violet Staining (0.1%).

Article Snippet: The proteins were electro-transferred to PVDF membranes, and blocked with 5% albumin bovine V (10735086001, Roche, USA) in Tris-buffered saline containing 0.5% Tween 20 (TBST buffer) at room temperature for 2 h. The membranes were then incubated overnight with the specific primary antibodies against CD147 (#13287), PI3K (#4249), p-PI3K (#4228), PDK1 (#5662), p-PDK1 (#3438), AKT (#9272), p-AKT (#4058), GLUT-1 (#12939) and GAPDH (#8884; all from Cell Signal Technology, USA).

Techniques: shRNA, Plasmid Preparation, Staining

Journal: Cell reports

Article Title: Transmembrane Protease TMPRSS11B Promotes Lung Cancer Growth by Enhancing Lactate Export and Glycolytic Metabolism

doi: 10.1016/j.celrep.2018.10.100

Figure Lengend Snippet: KEY RESOURCES TABLE

Article Snippet: Rabbit anti-human Basigin (E1S1V) , Cell Signaling Technology , Cat. # 13287S.

Techniques: Recombinant, Protease Inhibitor, Mutagenesis, Lysis, Transfection, Enzyme-linked Immunosorbent Assay, Lactate Assay, Immunoprecipitation, Bicinchoninic Acid Protein Assay, RNA Sequencing Assay, Binding Assay, Software

Journal: Cell reports

Article Title: Transmembrane Protease TMPRSS11B Promotes Lung Cancer Growth by Enhancing Lactate Export and Glycolytic Metabolism

doi: 10.1016/j.celrep.2018.10.100

Figure Lengend Snippet: KEY RESOURCES TABLE

Article Snippet: Rabbit anti-human Basigin (E1S1V) , Cell Signaling Technology , Cat. # 13287S.

Techniques: Recombinant, Protease Inhibitor, Mutagenesis, Lysis, Transfection, Enzyme-linked Immunosorbent Assay, Lactate Assay, Immunoprecipitation, Bicinchoninic Acid Protein Assay, RNA Sequencing Assay, Binding Assay, Software